Global Medtech CDMO Market Grows to $96.5B in 2025 as Pharma-Medtech Convergence Emerges as a Defining Accelerator

Got story updates? Submit your updates here. ›

Alira Health, a global healthcare consulting and research organization, has released its sixth annual report on the state of the contract development and manufacturing organization (CDMO) market in medtech. The findings show the global market reached $96.5 billion in 2025, reflecting 8.4% year-over-year growth, and is projected to grow to $143.6 billion by 2030 at a compound annual growth rate (CAGR) of 8.3%. The report highlights pharma-medtech convergence as a defining accelerator of growth, driving increased demand for integrated capabilities across drug and device development and manufacturing.

Why it matters

The medtech CDMO industry is undergoing a profound shift, as the boundaries between pharma and medtech are dissolving. CDMOs are evolving from manufacturers into indispensable strategic partners, with their ability to combine expertise in design, development, and advanced manufacturing technologies becoming critical. This convergence, alongside sustained market growth and continued consolidation, is fundamentally reshaping how therapies reach patients.

The details

Key findings from the report include: Drug delivery systems lead as the largest and fastest-growing segment, valued at $15.2 billion in 2025 and projected to grow at a 9.1% CAGR through 2030, driven by demand for combination products and the continued expansion of GLP-1 therapies. Deal activity reflects accelerating consolidation and strategic focus, with a total of 54 global deals completed in 2025, and 22% of transactions targeting drug delivery as consolidation increasingly centers on CDMOs capable of bridging pharma and medtech development cycles. Capability expansion supports integrated drug-device delivery, as CDMOs are expanding beyond traditional manufacturing into analytical testing, formulation support, and fill-finish services, with investments in micro-molding (37%), sterile packaging (43%), and precision machining (46%) prominent across 2025 deals.

• The global medtech CDMO market reached $96.5 billion in 2025.
• The market is projected to grow to $143.6 billion by 2030, at a CAGR of 8.3%.
• A total of 54 global deals were completed in 2025, with activity accelerating in the second half of the year.

What they’re saying

What’s next

As the market continues to evolve, CDMOs that can integrate cross-sector expertise and deliver end-to-end solutions are expected to be best positioned to capture future growth.